Parasramani Shrichand G, Kar Bikash R, Tahiliani Sushil, Parthasarathi Anchala, Neema Shekhar, Ganguly Satyaki, Sathishkumar Dharshini, Venkatachalam K, Komeravelli Haritha, Thomas Jayakar
From the Department of DVL, Lilavati Hospital, Mumbai, Maharashtra, India.
Department of DVL, IMS and SUM Hospital, Bhubaneswar, Odisha, India.
Indian J Dermatol. 2024 May-Jun;69(3):241-248. doi: 10.4103/ijd.ijd_165_24. Epub 2024 Jun 26.
Pustular psoriasis is a specialized variant of psoriasis which can be life threatening if not treated at the earliest. The pathogenesis has been recently linked to the role of interleukin 36. Apart from the corticosteroids, systemic antipsoriatics like acitretin, cyclosporine and methotrexate have been used with some success though unpredictable. With recent identification of role of IL-36 in the pathogenesis of pustular psoriasis, biologics targeting the IL-36 receptors have been used to manage the situation with high degree of success. This narrative review deals with the recent concepts of pathogenesis of pustular psoriasis as well as the current management scenario.
脓疱型银屑病是银屑病的一种特殊变体,如果不及早治疗可能会危及生命。其发病机制最近与白细胞介素36的作用有关。除了皮质类固醇外,全身性抗银屑病药物如阿维A、环孢素和甲氨蝶呤也已被使用,虽有一定成功但效果不可预测。随着最近发现IL-36在脓疱型银屑病发病机制中的作用,靶向IL-36受体的生物制剂已被用于成功控制病情。这篇叙述性综述探讨了脓疱型银屑病发病机制的最新概念以及当前的治疗情况。